articleThe LancetOct 28, 2006GREEN OA

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

ASAndré ScheenNFNick FinerPHPriscilla HollanderMDMichael D. JensenLFLuc F. Van Gaal

Centre Hospitalier Universitaire de Liège · University of Liège · +4 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

735
total citations
FWCI
104.16
Percentile
100%
References
59
Citations per year

Authors

5

Topics & keywords

Topics
Keywords
  • Rimonabant
  • Medicine
  • Tolerability
  • Placebo
  • Type 2 diabetes
  • Overweight
  • Metformin
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding